Endo Pharmaceuticals Holdings Inc. (ENDP) reported third-quarter net income of $49 million compared to $66 million last year. Reported earnings per share were $0.42 compared to $0.55 last year.
Adjusted net income was $74 million compared to $79 million prior year. Adjusted earnings per share were $0.63 compared to $0.66 last year.
On average, 23 analysts polled by Thomson Reuters expected the company to report profit of $0.65 per share for the quarter. Analysts' estimates typically exclude special items.
Total revenues increased to $361 million from $317 million last year. Analysts expected revenue of $365.33 million for the quarter.
The company raised guidance for 2009 annual total revenues and adjusted earnings per share.
The company now estimates total revenues to be between $1.440 billion-$1.465 billion.
The company now estimates reported earnings per share to be between $1.41 and $1.47.
For comments and feedback: editorial@rttnews.com